Patent details

301095 Product Name: calcifediol in iedere vorm zoals beschermd door het basisoctrooi

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301095
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2968172
Status:
Refused Art. 10 of the EC Regulations
Application number:
301095
Procedural language:
Dutch
First Applicant Residence Country:
Ireland (IE)

Marketing Authorization

1

Marketing Authorization Number:
2202115.00.00
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/08/2020
Marketing Authorization Country:
Germany (DE)

2

Marketing Authorization Number:
124799
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
22/09/2020
Marketing Authorization Country:
Netherlands (NL)

Dates

Filing date:
16/03/2021
First Marketing Authorization date:
19/08/2020
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
17/03/2021
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
04/02/2022

Applicant/holder

From:
16/03/2021
 
 

 

Name:
EirGen Pharma Ltd.
Address:
Westside Business Park Old Kilmeaden Road, Waterord X91 YV67, Ireland (IE)

Agent

Name:
ir. H.A. Witmans c.s.
From:
16/03/2021
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Opposition

Objection/ Appeal

1

Request Number:
000162
Filling Date:
18/03/2022
Requestor For Appeal Name:
EirGen Pharma Ltd.
Reason:
SPC Application Rejected
Type:
Objection
Status:
Completed
Decision:
Inadmissible
Decision Issued Date:
23/12/2022
Decision Summary:

2

Request Number:
000177
Filling Date:
11/05/2023
Requestor For Appeal Name:
EirGen Pharma Ltd.
Reason:
Rejected objection decision
Type:
Appeal (court)
Status:
Completed
Decision:
Withdrawn
Decision Issued Date:
08/08/2024
Decision Summary:

Publication

Bulletin

1

Bulletin Heading:
VB2
Journal edition number:
33/24
Publication date:
14/08/2024
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995 in respect of which a decision has been taken. Oppositon(s) decisions ex European Patent Convention

2

Bulletin Heading:
VB1
Journal edition number:
22/23
Publication date:
31/05/2023
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

3

Bulletin Heading:
VB2
Journal edition number:
52/22
Publication date:
28/12/2022
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995 in respect of which a decision has been taken. Oppositon(s) decisions ex European Patent Convention

4

Bulletin Heading:
VB1
Journal edition number:
12/22
Publication date:
23/03/2022
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

5

Bulletin Heading:
VRV
Journal edition number:
06/22
Publication date:
09/02/2022
Description:
Lapse or annulment

6

Bulletin Heading:
SPC
Journal edition number:
11/21
Publication date:
17/03/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Other

Note:
Octrooicentrum Nederland heeft bij besluit van 26 januari 2023 zijn besluit van 23 december 2022 ingetrokken, aangezien het besluit van 23 december 2022 op kennelijk onjuiste overwegingen was genomen. Dit houdt in dat de bezwaarprocedure is hervat.
Filing date Document type Document Description Number of pages File Type
08/08/2024 Appeal Withdrawal appeal procedure 2 PDF /9/6/5/3/6/0800663569/docs/301095_42_appeal20240808124136170.pdf
06/08/2024 Appeal Withdrawal appeal procedure 1 PDF /9/6/5/3/6/0800663569/docs/301095_41_appeal20240808093113277.pdf
04/07/2024 Appeal Accompanying letter appeal procedure 2 PDF /9/6/5/3/6/0800663569/docs/301095_40_appeal20240704013650431.pdf
02/07/2024 Appeal Outgoing correspondence appeal procedure 2 PDF /9/6/5/3/6/0800663569/docs/301095_38_appeal20240702032004777.pdf
02/07/2024 Appeal Outgoing correspondence appeal procedure 2 PDF /9/6/5/3/6/0800663569/docs/301095_39_appeal20240702031856583.pdf
01/03/2024 Appeal Accompanying letter appeal procedure 1 PDF /9/6/5/3/6/0800663569/docs/301095_22_appeal20240305013450366.pdf
01/02/2024 Outgoing Correspondence Letter 1 PDF /9/6/5/3/6/0800663569/docs/301095_24_588704l000.pdf
22/01/2024 Appeal Appeal 1 PDF /9/6/5/3/6/0800663569/docs/301095_23_appeal20240122025139212.pdf
11/05/2023 Appeal Annex 2 PDF /9/6/5/3/6/0800663569/docs/301095_26_appeal20230517023224358.pdf
11/05/2023 Appeal Annex 2 PDF /9/6/5/3/6/0800663569/docs/301095_27_appeal20230517023224383.pdf
11/05/2023 Appeal Accompanying letter appeal procedure 1 PDF /9/6/5/3/6/0800663569/docs/301095_28_appeal20230517023224323.pdf
11/05/2023 Appeal Annex 7 PDF /9/6/5/3/6/0800663569/docs/301095_29_appeal20230517023224453.pdf
11/05/2023 Appeal Annex 15 PDF /9/6/5/3/6/0800663569/docs/301095_30_appeal20230517023224479.pdf
11/05/2023 Appeal Annex 4 PDF /9/6/5/3/6/0800663569/docs/301095_31_appeal20230517023224423.pdf
02/02/2023 Outgoing Correspondence Letter 1 PDF /9/6/5/3/6/0800663569/docs/301095_32_529142l000.pdf
02/02/2023 Outgoing Correspondence Letter 2 PDF /9/6/5/3/6/0800663569/docs/301095_33_529154l000.pdf
01/02/2023 Outgoing Correspondence Decision appeal 2 PDF /9/6/5/3/6/0800663569/docs/301095_21_528206l073.pdf
23/01/2023 Appeal Mail appeal procedure 5 PDF /9/6/5/3/6/0800663569/docs/301095_20_appeal20230124101657017.pdf
23/12/2022 Outgoing Correspondence Decision appeal 2 PDF /9/6/5/3/6/0800663569/docs/301095_36_522015l073.pdf
12/08/2022 Appeal Annex 15 PDF /9/6/5/3/6/0800663569/docs/301095_34_appeal20221229030135527.pdf
12/08/2022 Appeal Annex 4 PDF /9/6/5/3/6/0800663569/docs/301095_35_appeal20221229030053037.pdf
19/05/2022 Outgoing Correspondence Letter to applicant 1 PDF /9/6/5/3/6/0800663569/docs/301095_25_481473l173.pdf
21/03/2022 Outgoing Correspondence Confirmation receipt appeal 1 PDF /9/6/5/3/6/0800663569/docs/301095_13_469544l072.pdf
18/03/2022 Appeal Request appeal 2 PDF /9/6/5/3/6/0800663569/docs/301095_0_appeal20220321033038226.pdf
04/02/2022 Outgoing Correspondence Decision refusal 7 PDF /9/6/5/3/6/0800663569/docs/301095_19_455591l527a.pdf
26/01/2022 Administration Internal New 2 PDF /9/6/5/3/6/0800663569/docs/301095_8_administration20220126150644006.pdf
25/01/2022 Examination Internal New 3 PDF /9/6/5/3/6/0800663569/docs/301095_4_examination20220125140123959.pdf
12/07/2021 Incoming Correspondence Paper Accompanying letter incoming document 26 PDF /9/6/5/3/6/0800663569/docs/301095_5_incomingcorrespondencepaper20210712051031806.pdf
12/07/2021 SPC Documents Annex SPC 1 PDF /9/6/5/3/6/0800663569/docs/301095_12_supplprotectioncertificate20210712051031905.pdf
02/06/2021 Incoming Correspondence Paper Accompanying letter incoming document 3 PDF /9/6/5/3/6/0800663569/docs/301095_15_incomingcorrespondencepaper20210603105743032.pdf
12/04/2021 Outgoing Correspondence Letter to applicant 4 PDF /9/6/5/3/6/0800663569/docs/301095_1_404452l173.pdf
12/04/2021 SPC Documents Annex SPC 7 PDF /9/6/5/3/6/0800663569/docs/301095_6_supplprotectioncertificate20210412023202852.pdf
17/03/2021 Outgoing Correspondence Confirmation receipt request 1 PDF /9/6/5/3/6/0800663569/docs/301095_7_400283l174.pdf
16/03/2021 SPC Documents SPC Documents 12 PDF /9/6/5/3/6/0800663569/docs/301095_2_supplprotectioncertificate20210317085941779.pdf
16/03/2021 SPC Documents Annex SPC 5 PDF /9/6/5/3/6/0800663569/docs/301095_3_supplprotectioncertificate20210317091511793.pdf
16/03/2021 SPC Documents Annex SPC 1 PDF /9/6/5/3/6/0800663569/docs/301095_9_supplprotectioncertificate20210317085522669.pdf
16/03/2021 Application Form First filed application form 3 PDF /9/6/5/3/6/0800663569/docs/301095_10_applicationform20210317085125783.pdf
16/03/2021 SPC Documents Annex SPC 6 PDF /9/6/5/3/6/0800663569/docs/301095_11_supplprotectioncertificate20210317091616828.pdf
16/03/2021 SPC Documents SPC Documents 1 PDF /9/6/5/3/6/0800663569/docs/301095_14_supplprotectioncertificate20210317085739424.pdf
16/03/2021 SPC Documents Summary of the characteristics of the product 14 PDF /9/6/5/3/6/0800663569/docs/301095_16_supplprotectioncertificate20210317090543225.pdf
16/03/2021 SPC Documents Annex SPC 14 PDF /9/6/5/3/6/0800663569/docs/301095_17_supplprotectioncertificate20210317091734229.pdf
16/03/2021 SPC Documents Marketing Authorization SPC 4 PDF /9/6/5/3/6/0800663569/docs/301095_18_supplprotectioncertificate20210317090247007.pdf
16/03/2021 SPC Documents Annex SPC 2 PDF /9/6/5/3/6/0800663569/docs/301095_37_supplprotectioncertificate20210317091933009.pdf